Why the study?
What is the variability of plasma heparin levels after a standard 5000 iu subcutaneous dose in patients awaiting total hip replacement?
What is the variability of plasma heparin levels after a standard 5000 iu subcutaneous dose in patients awaiting total hip replacement?
Standard low-dose subcutaneous heparin results in variable plasma levels, suggesting individualized monitoring may be necessary to optimize efficacy and safety.
Answers are grounded in this paper and cite their sources.
Variable heparin levels after fixed dosing without predictors support considering monitoring; leaves open whether titration improves VTE prevention in hip replacement.
Plasma heparin levels were measured at 2 and 8 h after 5000 iu of heparin subcutaneously in 43 patients awaiting total hip replacement. At 2 h, 37 patients had plasma levels between 0.05 and 0.15 iu/ml, three patients had more than 0.2 iu/ml, and three had only trace levels. At 8 h, most patients had less than 0.1 iu/ml, and six patients had no detectable plasma heparin. There were no correlations between plasma heparin levels and age, sex, body weight or use of analgesics. Patients with high 2 h plasma heparin levels may bleed at operation, whereas those with very low plasma heparin concentrations may be at risk of post-operative venous thrombosis; it may therefore sometimes be necessary to monitor plasma heparin levels in order to determine the optimal regime in individual cases.
No takes yet. Share an insight, caveat, or question.
Brozović et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: